You are here

Teva said to be close to buying generic drug unit of Allergan

Petah Tikva, Israel

TEVA Pharmaceuticals is in advanced talks to buy the generic drug division of Allergan for about US$45 billion, a person briefed on the matter said on Saturday.

A deal could be announced as soon as Monday, this person said, though talks are ongoing and may still...

Market voices on: